1. Jonas A. Lecithin cholesterol acyltransferase. Biochim Biophys Acta 1529:245-256; 2000.
2. Calabresi L, Pisciotta L, Costantin A, Frigerio I, Eberini I, Alessandrini P, Arca M, Bon GB, Boscutti G, Busnach G, Frasca G, Gesualdo L, Gigante M, Lupattelli G, Montali A, Pizzolitto S, Rabbone I, Rolleri M, Ruotolo G, Sampietro T, Sessa A, Vaudo G, Cantafora A, Veglia F, Calandra S, Bertolini S, and Franceschini G. The molecular basis of lecithin:cholesterol acyltransferase deficiency syndromes: a comprehensive study of molecular and biochemical findings in 13 unrelated Italian families. Arterioscler Thromb Vasc Biol 25:1972-1978; 2005.
3. Calabresi L, Baldassarre D, Castelnuovo S, Conca P, Bocchi L, Candini C, Frigerio B, Amato M, Sirtori CR, Alessandrini P, Arca M, Boscutti G, Cattin L, Gesualdo L, Sampietro T, Vaudo G, Veglia F, Calandra S, Franceschini G. Functional lecithin: cholesterol acyltransferase is not required for efficient atheroprotection in humans. Circulation 120:628-635; 2009.
4. Norum KR, and Gjone E. 1967. Familial serum-cholesterol esterification failure. A new inborn error of metabolism. Biochim Biophys Acta 144:698-700; 1967.
5. Santamarina-Fojo S, Hoeg JM, Assmann G, and Brewer HBJr. Lecithin cholesterol acyltransferase deficiency and fish eye disease. In The Metabolic and Molecular Bases of Inherited Diseases. Scriver CR, Beaudet AL, Sly WS, and Valle D, editors. McGraw-Hill. New York. 2817-2833; 2001.
6. Carlson LA, and Philipson B. 1979. Fish-eye disease. A new
familial condition with massive corneal opacities and
dyslipoproteinaemia. Lancet 2:922-924; 1979.